Molecular interaction of fibrinogen with zeolite nanoparticles.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 02 2019
Historique:
received: 22 05 2018
accepted: 10 12 2018
entrez: 9 2 2019
pubmed: 9 2 2019
medline: 20 8 2020
Statut: epublish

Résumé

Fibrinogen is one of the key proteins that participate in the protein corona composition of many types of nanoparticles (NPs), and its conformational changes are crucial for activation of immune systems. Recently, we demonstrated that the fibrinogen highly contributed in the protein corona composition at the surface of zeolite nanoparticles. Therefore, understanding the interaction of fibrinogen with zeolite nanoparticles in more details could shed light of their safe applications in medicine. Thus, we probed the molecular interactions between fibrinogen and zeolite nanoparticles using both experimental and simulation approaches. The results indicated that fibrinogen has a strong and thermodynamically favorable interaction with zeolite nanoparticles in a non-cooperative manner. Additionally, fibrinogen experienced a substantial conformational change in the presence of zeolite nanoparticles through a concentration-dependent manner. Simulation results showed that both E- and D-domain of fibrinogen are bound to the EMT zeolite NPs via strong electrostatic interactions, and undergo structural changes leading to exposing normally buried sequences. D-domain has more contribution in this interaction and the C-terminus of γ chain (γ

Identifiants

pubmed: 30733474
doi: 10.1038/s41598-018-37621-4
pii: 10.1038/s41598-018-37621-4
pmc: PMC6367512
doi:

Substances chimiques

Zeolites 1318-02-1
Fibrinogen 9001-32-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1558

Références

Biochemistry. 1977 Nov 15;16(23):5100-8
pubmed: 911814
Nanoscale. 2015 May 21;7(19):8978-94
pubmed: 25920546
J Magn Reson Imaging. 1995 Sep-Oct;5(5):499-508
pubmed: 8574032
Nat Nanotechnol. 2011 Jan;6(1):39-44
pubmed: 21170037
Spectrochim Acta A Mol Biomol Spectrosc. 2011 Dec;83(1):130-5
pubmed: 21890401
ACS Appl Mater Interfaces. 2016 Nov 16;8(45):30768-30779
pubmed: 27766857
Acta Biochim Biophys Sin (Shanghai). 2008 Sep;40(9):777-82
pubmed: 18776989
Nanoscale. 2018 Apr 19;10(15):7108-7115
pubmed: 29616243
AAPS PharmSciTech. 2018 Apr;19(3):1133-1140
pubmed: 29218583
Nanoscale. 2013 Sep 7;5(17):8130-7
pubmed: 23884371
Acc Chem Res. 2002 Jun;35(6):358-65
pubmed: 12069620
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
pubmed: 17267609
Nanoscale. 2011 Mar;3(3):1127-38
pubmed: 21210042
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Nanoscale. 2013 Apr 21;5(8):3240-4
pubmed: 23508197
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
ACS Nano. 2013 Aug 27;7(8):6555-62
pubmed: 23808533
Chem Soc Rev. 2012 Apr 7;41(7):2780-99
pubmed: 22086677
J Am Chem Soc. 2012 Mar 7;134(9):4100-3
pubmed: 22339401
Chem Commun (Camb). 2009 Apr 7;(13):1661-3
pubmed: 19294254
ACS Nano. 2012 Oct 23;6(10):8962-9
pubmed: 22998416
Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37
pubmed: 19376175
Trends Biotechnol. 2012 Oct;30(10):499-511
pubmed: 22884769
J Alzheimers Dis. 2017;59(4):1187-1202
pubmed: 28759965
Chem Rev. 2011 Sep 14;111(9):5610-37
pubmed: 21688848
Nanoscale. 2013 Sep 7;5(17):8242-8
pubmed: 23884109
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
ACS Chem Neurosci. 2018 Jul 18;9(7):1725-1734
pubmed: 29676567
Nano Lett. 2014 Jan 8;14(1):6-12
pubmed: 24328336
J Phys Chem B. 2012 Aug 2;116(30):8901-7
pubmed: 22774860
ACS Nano. 2014 Apr 22;8(4):3357-66
pubmed: 24617595
Colloids Surf B Biointerfaces. 2015 Dec 1;136:1107-12
pubmed: 26613856
Sci Rep. 2015 Nov 30;5:17259
pubmed: 26616161
J Biophys Biochem Cytol. 1959 Jan 25;5(1):11-6
pubmed: 13630928
J Am Chem Soc. 2006 Mar 29;128(12):3939-45
pubmed: 16551101
Trends Biotechnol. 2017 Oct;35(10):937-953
pubmed: 28666544
Science. 2012 Jan 6;335(6064):70-3
pubmed: 22157080
J Am Chem Soc. 2005 Jun 8;127(22):8168-73
pubmed: 15926845
Chem Rev. 2013 Mar 13;113(3):1877-903
pubmed: 23157552
ACS Appl Mater Interfaces. 2016 Feb 10;8(5):3123-34
pubmed: 26771200
Nat Nanotechnol. 2009 Sep;4(9):577-80
pubmed: 19734930
Nanoscale. 2018 Jan 18;10(3):1228-1233
pubmed: 29292453
Biomater Sci. 2014 Sep 29;2(9):1210-1221
pubmed: 32481892
ACS Nano. 2010 Jan 26;4(1):365-79
pubmed: 20020753
J Am Chem Soc. 2010 Apr 28;132(16):5761-8
pubmed: 20356039
Nanomedicine. 2016 Feb;12(2):287-307
pubmed: 26707817

Auteurs

Hossein Derakhshankhah (H)

Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Pharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Atiyeh Hosseini (A)

Institute for Nanoscience and Nanotechnology and Center of Excellence in Complex Systems and Condensed Matter (CSCM), Sharif University of Technology, Tehran, 1458889694, Iran.

Fereshteh Taghavi (F)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Samira Jafari (S)

Pharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Alireza Lotfabadi (A)

Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Pharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Mohammad Reza Ejtehadi (MR)

Department of Physics, Sharif University of Technology, P. O. Box 11155-9161, Tehran, Iran.
Center of Excellence in Complex Systems and Condensed Matter (CSCM), Sharif University of Technology, Tehran, 1458889694, Iran.

Sahba Shahbazi (S)

School of Biology College of Science, University of Tehran, Tehran, Iran.

Ali Fattahi (A)

Pharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Atiyeh Ghasemi (A)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Ebrahim Barzegari (E)

Pharmacutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mina Evini (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Ali Akbar Saboury (AA)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Seyed Mehdi Kamali Shahri (SMK)

Department of Chemical Engineering, Pennsylvania State University, University Park, PA, 16802, United States.

Behnaz Ghaemi (B)

Department of Medical Nanotechnology, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, 1417755469, Iran.

Eng-Poh Ng (EP)

School of Chemical Sciences, Universiti Sains Malaysia, Gelugor, 11800 USM, Malaysia.

Hussein Awala (H)

Laboratory of Catalysis and Spectroscopy, ENSICAEN, University of Caen, CNRS, 6 Boulevard du Marechal Juin, 14050, Caen, France.

Fatemeh Omrani (F)

Persian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran.

Iraj Nabipour (I)

Persian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran.

Mohammad Raoufi (M)

Nanotechnology Research Center, Faculty of Pharmacy, Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 13169-43551, Iran.

Rassoul Dinarvand (R)

Nanotechnology Research Center, Faculty of Pharmacy, Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 13169-43551, Iran.

Koorosh Shahpasand (K)

Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Svetlana Mintova (S)

Laboratory of Catalysis and Spectroscopy, ENSICAEN, University of Caen, CNRS, 6 Boulevard du Marechal Juin, 14050, Caen, France. mintova@ensicaen.fr.

Mohammad Javad Hajipour (MJ)

Persian Gulf Marine Biotechnology Research Center, the Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, 75147, Iran. mj.hajipour@ncdrc.info.
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, 13169-43551, Iran. mj.hajipour@ncdrc.info.

Morteza Mahmoudi (M)

Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, United States. mmahmoudi@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH